Trial of the Heart

Doug Bergman drove 240 miles to have his heart stabbed by a needle from the inside out. Now he hopes the stem cells that may be in that needle will change his life. By Ivan Oransky WEB EXTRA View Slideshow of Bergman's day Related Article: Making a Play at Regrowing Hearts Results from the first round of controlled human stem cell trials for heart disease are in. What have we learned? Web Extras: Clinical Trials Database A sortabl

Written byIvan Oransky
| 11 min read

Register for free to listen to this article
Listen with Speechify
0:00
11:00
Share

Doug Bergman drove 240 miles to have his heart stabbed by a needle from the inside out. Now he hopes the stem cells that may be in that needle will change his life.

WEB EXTRA

View Slideshow of Bergman's day



It's just before 2 p.m. on a Tuesday in August, and Doug Bergman and his sister are waiting patiently in his room on the cardiology floor of the Minneapolis Heart Institute. There's a copy of Elie Wiesel's Night on the table by his bed. For a man about to have a needle stuck into his heart ten times, Bergman is remarkably calm.

Bergman, who lives 240 miles away in Rochert, Minnesota, has been in Minneapolis since the previous Saturday. He's taking part in ACT34-CMI, a clinical trial designed to test whether injection of autologous CD34+ cells directly into the myocardium will reduce the number of anginal episodes suffered by ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies